Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Tomoki, Tamura"'
Autor:
Kohei Miyake, Satoru Senoo, Ritsuya Shiiba, Junko Itano, Goro Kimura, Tatsuyuki Kawahara, Tomoki Tamura, Kenichiro Kudo, Tetsuji Kawamura, Yasuharu Nakahara, Hisao Higo, Daisuke Himeji, Nagio Takigawa, Nobuaki Miyahara, Okayama Respiratory Disease Study Group (ORDSG)
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0292507 (2024)
ObjectiveLong-term steroid use increases the risk of developing Pneumocystis pneumonia (PcP), but there are limited reports on the relation of long-term steroid and PcP mortality.MethodsRetrospective multicenter study to identify risk factors for PcP
Externí odkaz:
https://doaj.org/article/1496a60398f248d0940415bb8881f7ba
Autor:
Daijiro Harada, Tomoki Tamura, Kiichiro Ninomiya, Toshio Kubo, Shoichi Kuyama, Sayaka Tachibana, Koji Inoue, Kenichi Chikamori, Kenichiro Kudo, Nobuaki Ochi, Yoshinobu Maeda, Katsuyuki Kiura
Publikováno v:
Thoracic Cancer, Vol 14, Iss 3, Pp 231-236 (2023)
Abstract Background COVID‐19 incidence is high in patients with cancer. The fatality rate was high for the Delta variant, necessitating infection prevention by vaccination. This study evaluated the safety of a SARS‐CoV‐2 vaccine in patients wit
Externí odkaz:
https://doaj.org/article/97bb7b8b8c774c5ea9342c7b835db576
Autor:
Takayuki Kakimoto, Tomoki Tamura, Taisaku Koyanagi, Takahiro Umeno, Kazuya Nishii, Shoichi Kuyama
Publikováno v:
Respiratory Medicine Case Reports, Vol 46, Iss , Pp 101927- (2023)
A 79-year-old man presented with fatigue and right shoulder pain. Computed tomography revealed right pleural effusion and osteosclerosis of the sternoclavicular joint. There were no signs of malignancy or infection in the pleural fluid studies. His b
Externí odkaz:
https://doaj.org/article/5b75fa2db0dd4b7683d089d55cd6239b
Autor:
Tomoki Tamura, Sakura Hata, Takahiro Baba, Taisaku Koyanagi, Takahiro Umeno, Kazuya Nishii, Shoichi Kuyama
Publikováno v:
Respiratory Medicine Case Reports, Vol 45, Iss , Pp 101911- (2023)
Tepotinib is one of the key drugs for MET exon 14-skipping mutation-positive non-small cell lung cancer (NSCLC). The main adverse event of tepotinib treatment is edema. Rash is a rare adverse event, affecting only 0.7% of patients. We report a case o
Externí odkaz:
https://doaj.org/article/a7c50fb80f2c4a86902764bb8ed329c1
Autor:
Tomoki Tamura, Kiichiro Ninomiya, Toshio Kubo, Shoichi Kuyama, Sayaka Tachibana, Koji Inoue, Kenichi Chikamori, Kenichiro Kudo, Nobuaki Ochi, Daijiro Harada, Yoshinobu Maeda, Katsuyuki Kiura
Publikováno v:
Thoracic Cancer, Vol 13, Iss 3, Pp 453-459 (2022)
Abstract Background Since 2020, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has become prevalent worldwide. In severe cases, the case fatality rate is high, and vaccine prevention is important. This study evaluated the safety of
Externí odkaz:
https://doaj.org/article/424ceb059e7e4c87aac9877f602b5941
Autor:
Kengo Mori, Kazuya Nishii, Wataru Kitamura, Tomohiro Urata, Takahiro Baba, Hiroki Omori, Masamoto Nakanishi, Tomoki Tamura, Shoichi Kuyama
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 8, Iss , Pp 100192- (2022)
A 74-year-old woman with squamous cell lung cancer (cT3N1M0, c-stage IIIA) was treated with durvalumab after chemoradiotherapy. At the beginning of the fourth treatment, Grade 2 (Common Terminology Criteria for Adverse Events ver5.0) radiotherapy-
Externí odkaz:
https://doaj.org/article/5419b586ac3a48e88aff066fc9b1f8b9
Publikováno v:
Thoracic Cancer, Vol 12, Iss 18, Pp 2513-2516 (2021)
Abstract Primary salivary gland‐type tumors of the lung are rare, accounting for
Externí odkaz:
https://doaj.org/article/99c3b1deb8f54113a118c500f217d317
Publikováno v:
Thoracic Cancer, Vol 12, Iss 11, Pp 1770-1774 (2021)
Abstract Epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) are key drugs in the treatment of non‐small cell lung cancer (NSCLC) patients with EGFR mutations; however, first‐generation EGFR‐TKIs, such as gefitinib and e
Externí odkaz:
https://doaj.org/article/2c807d8d7d844920a8558d9832b3dd29
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 1, Pp 197-201 (2021)
Alectinib is a key drug for treating anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC). Alectinib-induced hepatotoxicity is less common than that through other ALK inhibitors, such as crizotinib or ceritinib. Herein, we des
Externí odkaz:
https://doaj.org/article/19b6301b8c1446b0a0f06af7dafdfe94
Autor:
Susumu Doita, Tomoki Tamura, Takahiro Baba, Hiroki Oomori, Kazuya Nishii, Masamoto Nakanishi, Shoichi Kuyama
Publikováno v:
Respiratory Medicine Case Reports, Vol 37, Iss , Pp 101654- (2022)
Immunoglobulin G4 (IgG4)-related pleurisy is a rare type of IgG4-related disease. We present the case of a 69-year-old woman with left pleural effusion and elevated adenosine deaminase levels. Initially, tuberculous pleuritis was suspected; however,
Externí odkaz:
https://doaj.org/article/f2ab72aaf6ab461ba37755c7bdcec88d